The 69th Annual Meeting of the Japanese Society for Virology

Session information

Oral

[O2-4] SARS2-5

Mon. Nov 14, 2022 4:50 PM - 6:20 PM Room 4 (Conference Room 107)

Chair:Hideki Tani(Toyama Institute of Health), Wakako Furuyama(National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University)

4:50 PM - 5:05 PM

*Yohei Seki1, Kiyoko Nojima1, Haruka Momose1, Shuetsu Fukushi2, Saya Moriyama 3, Yoshimasa Takahashi 3, Ken Maeda4, Tadaki Suzuki5, Takuo Mizukami1, Yasuo Yoshihara6, Isao Hamaguchi1 (1. Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, 2. Department of Virology 1, National Institute of Infectious Diseases, 3. Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 4. Department of Veterinary Science, National Institute of Infectious Diseases, 5. Department of Pathology, National Institute of Infectious Diseases, 6. National Hospital Organization Murayama Medical Center)

5:05 PM - 5:20 PM

*Atsuhiko Sakamoto1,2,3, Michinobu Yoshimura2, Ryota Ito2, Kazunari Ishii2, Ryo Ozuru2, Yusuke Kurihara2, Yusuke Sechi3, Aya Fujikane3, Kenji Hiromatsu2, Shigeki Nabeshima3 (1. Fukuoka University, 2. Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, 3. General Medicine, Fukuoka University Hospital)

5:20 PM - 5:35 PM

*Soichiro Kawata1,5, Jiun-Yu Jian2, Shusaku Mizukami2, Shinpei Morimoto3, Meng Ling Moi4, Koichi Morita4, Setsuko Hirakura4, Yutaro Yamagata5, Hirono Otomaru5, Michiko Toizumi5, Lay Myint Yoshida5, Masako Moriuchi6,1, Hiroyuki Moriuchi6,1 (1. Department of Pediatrics, Nagasaki University Hospital, 2. Department of Immunogenetics, Institute of Tropical Medicine, Nagasaki University, 3. Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, 4. Department of Virology, Institute of Tropical Medicine, Nagasaki University, 5. Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, 6. Department of Pediatrics, Nagasaki University Graduate School of Biomedical Sciences)

5:35 PM - 5:50 PM

*Ryota Otsubo1, Takeharu Minamitani2, Kouji Kobiyama3,7, Ken-Ichi Imadome4, Ken J. Ishii3,7, Kouhei Tumoto5,8,9, Wataru Kamitani6, Teruhito Yasui1 (1. Laboratory of Infectious Diseases and Immunity, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, 2. Toyama Prefectural Institute for Pharmaceutical Research, 3. Division of Vaccine Science, Department of Microbiology and immunology, The institute of Medical Science, The University of Tokyo, 4. Department of Advanced Medicine for Infections, National Center for Child Health and Development, 5. Center for Drug Design Research, National Institutes of Biomedical Innovation, Health and Nutrition, 6. Department of Infectious Diseases and Host Defense, Graduate School of Medicine, Gunma University, 7. Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, 8. Department of Bioengineering, School of Engineering, The University of Tokyo, 9. Institute of Medical Science, The University of Tokyo)

5:50 PM - 6:05 PM

*Mizuki Yamamoto1, Jin Gohda1, Ayako Kobayashi1, Keiko Tomita1, Youko Hirayama1, Naohiko Koshikawa2, Motoharu Seiki3, Kentaro Semba4, Tetsu Akiyama5, Yasushi Kawaguchi6, Jun-ichiro Inoue7 (1. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo, 2. Department of Life Science and Technology, Tokyo Institute of Technology, 3. Division of Cancer Cell Research, The Institute of Medical Science, The University of Tokyo, 4. Department of Life Science and Medical Bio-Science, Waseda University, 5. Laboratory of Molecular and Genetic Information, Institute for Quantitative Biosciences, The University of Tokyo, 6. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 7. Research Platform Office, The Institute of Medical Science, The University of Tokyo)

6:05 PM - 6:20 PM

*Hesham Nasser1, Rigel Suzuki2, Mai Kishimoto3, Ryo Shimizu1, the Genotype to Phenotype Japan (G2P-Japan), Akatsuki Saito4, Kei Sato5, Keita Matsuno3, Takasuke Fukuhara2, Terumasa Ikeda1 (1. Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan, 2. Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, 4. Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan, 5. Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

×

Authentication

×

Please log in with your participant account.
» Participant Log In